Paul Hastings Advises Nanosphere, Inc. in its Initial Public Offering

November 06, 2007

Paul Hastings Advises Nanosphere, Inc. in its Initial Public Offering

Los Angeles, CA (November 6, 2007) – Paul, Hastings, Janofsky & Walker LLP, a leading international law firm, announced today that the firm advised Nanosphere, Inc., a nanotechnology-based molecular diagnostics company, in its initial public offering of 7 million shares of its common stock at $14 per share. Nanosphere’s common stock began trading on November 1, 2007 on NASDAQ Global Market under the symbol “NSPH.”

Partner Esteban Ferrer and of Counsel Ann Lawrence led the Paul Hastings team, which included associate Angelique Crain.

Under the terms of the deal, Nanosphere’s underwriter, Credit Suisse Securities (USA) LLC purchased an additional 1,050,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

About Nanosphere, Inc.: Based in Northbrook, IL, Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene ® System for direct genomic and ultra-sensitive protein detection.

Paul, Hastings, Janofsky & Walker LLP, founded in 1951, is a leading international law firm with over 1,200 attorneys in 18 offices. The firm serves a diverse client base including many of the leading global financial institutions and Fortune 500 companies and offers deep capabilities in capital markets, finance and restructuring, intellectual property, international arbitration and dispute resolution, investment management, labor and employment, mergers and acquisitions, private equity, product liability, project finance, real estate, securities litigation and tax advisory services. For additional information, please visit our website at www.paulhastings.com.